| Lung Cancer |
1 |
0.91 |
| Non-Small Cell Lung Cancer |
0 |
0.69 |
| Biologic Therapy |
0 |
0.68 |
| Cancer |
0 |
0.64 |
| Sickle Cell Anemia |
0 |
0.62 |
| Toxicology |
0 |
0.46 |
| Small Cell Lung Cancer |
0 |
0.41 |
| Europe |
0 |
0.38 |
| Chemotherapy |
0 |
0.32 |
| Hemolytic Anemia |
0 |
0.27 |
| Blood |
0 |
0.26 |
| Hemoglobin |
0 |
0.26 |
| Blood Transfusion |
0 |
0.22 |
| Stem Cell Research and Therapy |
0 |
0.2 |
| Anemia |
0 |
0.19 |
| Platinum |
0 |
0.19 |
| Hodgkin Lymphoma |
0 |
0.14 |
| Antibody Drug Conjugates |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.13 |
| Cell Transplantation |
0 |
0.09 |
| Child |
0 |
0.06 |
| Immunotherapy |
0 |
0.06 |
| Lung |
0 |
0.06 |
| Stevens-Johnson Syndrome |
0 |
0.06 |
| Toxic Epidermal Necrolysis |
0 |
0.06 |
| Transfusion |
0 |
0.06 |
| Transplantation |
0 |
0.06 |